
Why Innovation and Access Matter to Dr. John M. Rosen, Pediatric Neurogastroenterologist
In this episode of Matters.com Presents, Mike interviews John M. Rosen.John M. Rosen, a pediatric neurogastroenterologist and digital health innovator, sits down to talk about what really matters to him right now: using technology to improve healthcare access for kids. From telehealth visits that help a teenager with autism get care from the comfort of his own couch, to AI-powered tools that put health information directly in the hands of parents, John makes a compelling case for why innovation in pediatric GI care is long overdue. He also pulls back the curtain on Pooficient, his new app designed to help families tackle constipation and GI health — and yes, even shares the story of taking his own toddler to the ER for what turned out to be constipation after all his years of training.[00:22] John M. Rosen shares what matters most to him: using technology to improve kids' health[00:33] How telehealth is eliminating the need for families to travel hundreds of miles to see specialists[00:54] A real-world example: how virtual visits transformed care for a teenager with autism[02:38] How digital record-sharing and AI are putting health knowledge in parents' hands[03:18] Introducing Pooficient: the app helping families navigate pediatric GI health[04:51] The surprising scale of childhood constipation and why it's still a taboo topic[06:20] John M. Rosen's honest confession: taking his own toddler to the ER for constipation[07:49] The sophisticated AI behind Pooficient and what makes it stand out[08:07] Speed round begins[08:22] Matters.com Speed Round: Pediatric Gastroenterology, Pizza, Telemedicine, Artificial Intelligence, Coffee, Mental HealthYou can find John M. Rosen at:https://www.linkedin.com/in/johnmrosen/https://www.pooficient.com/This podcast is brought to you by Matters.com. A new social media and collaboration platform - launching soon. Join thousands getting the Matters.com newsletter — world news, fresh perspectives, and early beta access.









